Previous 10 | Next 10 |
Citius Pharmaceuticals, Inc. Announces Positive Recommendation by Independent Data Monitoring Committee to Continue the Mino-Lok® Phase 3 Trial as Planned - DMC interim safety and efficacy review of Mino-Lok® Phase 3 Trial concluded with favorable recommendation to con...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips In the last few quarters, Reddit penny stocks have been game-changers for many portfolios. Penny stocks surging five or ten-fold in a few months seems like the new normal. Of course, it makes sense to stick to value investi...
How to Find The Best Biotech Penny Stocks to Buy in 2021 Biotech penny stocks have become some of the most popular stocks to watch in 2021. This began at the start of the pandemic after many leading penny stocks in the biotech industry fell in value substantially. While this made se...
This selection article continues a four-year ad hoc test of published studies that the Russell reconstitution generates excess risk-adjusted returns. In my prior three-year study from 2017, abnormal gains were identified from the annual June rebalancing and some profitable strategies ...
Citius Pharmaceuticals Inc. (NASDAQ:CTXR) traded today at a new 52-week high of $4.23. Approximately 2.8 million shares have changed hands today, as compared to an average 30-day volume of 7.9 million shares. Citius Pharmaceuticals Inc is a specialty pharmaceutical company. The company i...
SeaChange International (SEAC) +26% on insider buying.ReTo Eco-Solutions (RETO) +21% after announcing new iron tailings project.Achieve Life Sciences (ACHV) +17%.Jiuzi Holdings, Inc. (JZXN) +15%.Tiziana Life Sciences PLC (TLSA) +11% on agreement with FHI Clinical to conduct Pha...
Shares of Citius Pharmaceuticals (NASDAQ: CTXR) have shot about 270% higher this year. That's an amazing run for a biotech stock that most of us hadn't even heard of yet. Now that the stock has produced some eye-popping gains, investors of all stripes want to know if it can deli...
Citius Pharmaceuticals Inc. (NASDAQ:CTXR) traded today at a new 52-week high of $3.94. This new high was reached on below average trading volume as 2.8 million shares traded hands, while the average 30-day volume is approximately 7.9 million shares. Citius Pharmaceuticals Inc is a specia...
3 Penny Stocks to Watch in July 2021 With July around the corner, investors are searching for the best penny stocks to buy. While this can be challenging if you don’t have the right information, we’re here to help! The key to profiting from penny stocks is a combinatio...
Shares of Citius Pharmaceuticals Inc. (NASDAQ:CTXR) traded at a new 52-week high today of $3.86. Approximately 2.8 million shares have changed hands today, as compared to an average 30-day volume of 6.3 million shares. Citius Pharmaceuticals Inc. (NASDAQ:CTXR) is currently priced 17.5% a...
News, Short Squeeze, Breakout and More Instantly...
Citius Pharmaceuticals Inc. Company Name:
CTXR Stock Symbol:
NASDAQ Market:
Citius Pharmaceuticals Inc. Website:
2024-07-18 10:20:00 ET July 18, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at biotech/biopharma stocks, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:CTXR ), a late-stage biopharmaceutical compa...
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - July 18, 2024) - Investorideas.com , a go-to investing platform releases the second of a two-part series looking at biotech/biopharma stocks, featuring Citius Pharmaceuticals, Inc. (NASDAQ: CTXR), a late-stage biopharmaceutical c...
2024-07-17 10:10:00 ET July 17, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the first of a two-part series looking at biotech/biopharma stocks, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:CTXR ), a late-stage biopharmaceutical compan...